Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer

被引:376
|
作者
Singer, PA
Cooper, DS
Daniels, GH
Ladenson, PW
Greenspan, FS
Levy, EG
Braverman, LE
Clark, OH
McDougall, IR
Ain, KV
Dorfman, SG
机构
[1] UNIV SO CALIF,SCH MED,DIV ENDOCRINOL DIABET & HYPERTENS,LOS ANGELES,CA
[2] JOHNS HOPKINS UNIV,SCH MED,DIV ENDOCRINOL,BALTIMORE,MD
[3] MT SINAI HOSP,DIV ENDOCRINOL,BALTIMORE,MD
[4] MASSACHUSETTS GEN HOSP,THYROID UNIT,BOSTON,MA 02114
[5] UNIV CALIF SAN FRANCISCO,SCH MED,DIV ENDOCRINOL,SAN FRANCISCO,CA
[6] UNIV MIAMI,SCH MED,DIV ENDOCRINOL,MIAMI,FL
[7] UNIV MASSACHUSETTS,SCH MED,DIV ENDOCRINOL,WORCESTER,MA
[8] UNIV CALIF SAN FRANCISCO,MT ZION MED CTR,SCH MED,DEPT SURG,SAN FRANCISCO,CA 94120
[9] STANFORD UNIV,MED CTR,SCH MED,DIV NUCL MED,STANFORD,CA 94305
[10] UNIV KENTUCKY,DIV ENDOCRINOL,LEXINGTON,KY
[11] ENDOCRINE ASSOCIATES DALLAS,DALLAS,TX
关键词
D O I
10.1001/archinte.156.19.2165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with thyroid nodules or thyroid cancer was developed by consensus by an Ii-member Standards of Care Committee (the authors of the article) of the American Thyroid Association, New York, NY. The participants were selected by the committee chairman and by the president of the American Thyroid Association based on their clinical experience. The committee members represented different geographic areas within the United States, to reflect different practice patterns. The guidelines were developed based on the expert opinion of the committee participants, as well as on previously published information. Each committee participant was initially assigned to write a section of the document and to submit it to the committee chairman, who revised and assembled the sections into a complete draft document, which was then circulated among all committee members for further revision. Several of the committee members further revised and refined the document, which was then submitted to the entire membership of the American Thyroid Association for written comments and suggestions, many of which were incorporated into a final draft document, which was reviewed and approved by the Executive Council of the American Thyroid Association.
引用
收藏
页码:2165 / 2172
页数:8
相关论文
共 50 条
  • [31] WELL-DIFFERENTIATED THYROID-CANCER - FOREWORD
    WELLS, SA
    CURRENT PROBLEMS IN SURGERY, 1994, 31 (12) : 937 - 1012
  • [32] The Treatment of Well-Differentiated Thyroid Carcinoma Reply
    Paschke, Ralf
    Dralle, Henning
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (42): : 722 - 722
  • [33] Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
    So, Kevin
    Smith, Robin E.
    Davis, Sidney R.
    ANZ JOURNAL OF SURGERY, 2016, 86 (09) : 696 - 700
  • [34] Molecular markers for well-differentiated thyroid cancer
    Cherenko, SM
    Gorobeyko, MB
    Savchenko, VG
    EXPERIMENTAL ONCOLOGY, 2002, 24 (02) : 83 - 88
  • [35] Cytologic determinants of well-differentiated thyroid cancer
    Charles, MA
    Heller, KS
    AMERICAN JOURNAL OF SURGERY, 1997, 174 (05): : 545 - 547
  • [36] Sentinel lymphadenectomy in well-differentiated thyroid cancer
    Tsugawa, K
    Noguchi, M
    Bandoh, E
    Miwa, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (04): : S73 - S73
  • [37] Management of the Neck in Well-Differentiated Thyroid Cancer
    Asimakopoulos, Panagiotis
    Shaha, Ashok R.
    Nixon, Iain J.
    Shah, Jatin P.
    Randolph, Gregory W.
    Angelos, Peter
    Zafereo, Mark E.
    Kowalski, Luiz P.
    Hartl, Dana M.
    Olsen, Kerry D.
    Rodrigo, Juan P.
    Vander Poorten, Vincent
    Makitie, Antti A.
    Sanabria, Alvaro
    Suarez, Carlos
    Quer, Miquel
    Civantos, Francisco J.
    Robbins, K. Thomas
    Guntinas-Lichius, Orlando
    Hamoir, Marc
    Rinaldo, Alessandra
    Ferlito, Alfio
    CURRENT ONCOLOGY REPORTS, 2020, 23 (01)
  • [38] Well-differentiated thyroid cancer: Thyroidectomy or lobectomy?
    Kluijfhout, Wouter P.
    Rotstein, Lorne E.
    Pasternak, Jesse D.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (17-18) : E517 - E520
  • [39] Molecular markers in well-differentiated thyroid cancer
    Anil K. D’Cruz
    Richa Vaish
    Abhishek Vaidya
    Iain J. Nixon
    Michelle D. Williams
    Vincent Vander Poorten
    Fernando López
    Peter Angelos
    Ashok R. Shaha
    Avi Khafif
    Alena Skalova
    Alessandra Rinaldo
    Jennifer L. Hunt
    Alfio Ferlito
    European Archives of Oto-Rhino-Laryngology, 2018, 275 : 1375 - 1384
  • [40] Molecular markers in well-differentiated thyroid cancer
    D'Cruz, Anil K.
    Vaish, Richa
    Vaidya, Abhishek
    Nixon, Iain J.
    Williams, Michelle D.
    Poorten, Vincent Vander
    Lopez, Fernando
    Angelos, Peter
    Shaha, Ashok R.
    Khafif, Avi
    Skalova, Alena
    Rinaldo, Alessandra
    Hunt, Jennifer L.
    Ferlito, Alfio
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (06) : 1375 - 1384